KEVIN DAVIS: Open Payments
NPI 1811903529 · HINDMAN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$585 in 30 payments from 9 companies in 2025. Trend: 2023 $111 · 2024 $105 · 2025 $585
Food & beverage: $585
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $163 |
| Vanda Pharmaceuticals Inc. | 8 | $149 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $85 |
| Grifols USA, LLC | 3 | $61 |
| GlaxoSmithKline, LLC. | 3 | $42 |
| Dexcom, Inc. | 1 | $27 |
| Alkermes, Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: VRAYLAR, HETLIOZ, CAPLYTA, Prolastin-C Liquid, TRELEGY ELLIPTA, Dexcom G6 Transmitter, ARISTADA, FREESTYLE LIBRE 3.
Industry payments across KY — which companies pay providers there.
